-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Bt9yymR59kNvhEPFDe/R+LuQL6FLgd95okAIipbQGix2xAJRfUfOsc72kOkUymCE FRP9KoAvvPOIHOC8LKmqrQ== 0000912057-02-010515.txt : 20020415 0000912057-02-010515.hdr.sgml : 20020415 ACCESSION NUMBER: 0000912057-02-010515 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20020315 ITEM INFORMATION: Changes in registrant's certifying accountant ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20020319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TULARIK INC CENTRAL INDEX KEY: 0000889057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943148800 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-28397 FILM NUMBER: 02578926 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508257300 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 a2073790z8-k.htm 8-K

 

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


FORM 8-K


 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): March 15, 2002

 

TULARIK INC.

(Exact name of registrant as specified in its charter)

 

 

 

DELAWARE

 

000-28347

 

94–3148800

(State or other jurisdiction of incorporation)

 

(Commission File No.)

 

(I.R.S. Employer Identification No.)

 

 

Two Corporate Drive

South San Francisco, CA 94080

(Address of principal executive offices, including zip code)

 

(650) 825-7000

(Registrant’s telephone number, including area code)

 

 

 

 

 



 

Item 4. Changes in Registrant’s Certifying Accountants

 

On March 15, 2002, the Company dismissed Ernst & Young LLP as the independent accountants of the Company. On March 15, 2002 the Company appointed PricewaterhouseCoopers LLP as its independent auditors. The decision to change independent accountants has been approved by the Audit Committee under authority granted by the Board of Directors of the Company.

 

Ernst & Young’s reports on the Company’s financial statements for each of the fiscal years ended December 31, 2001 and 2000 did not contain an adverse opinion or disclaimer of opinion, nor were the reports qualified or modified as to uncertainty, audit scope or accounting principles, except for Ernst & Young’s reports dated February 4, 2002 and February 8, 2001 on the Company’s consolidated financial statements for the years ended December 31, 2001 and 2000 which refer to Note 1 to the Company’s consolidated financial statements, and noted that during the year ended December 31, 2000, the Company changed its method of revenue recognition for non-refundable technology access fees received in connection with collaboration agreements.

 

In connection with the Company’s audits for the fiscal years ended December 31, 2001 and 2000, and through March 14, 2002, there were no disagreements, as defined by Item 304 (a)(1)(iv) of Regulation S-K, between the Company and Ernst & Young on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Ernst & Young, would have caused Ernst & Young to make reference thereto in their reports on the Company’s financial statements for such years.

 

During the fiscal years ended December 31, 2001 and 2000, and through March 14, 2002, there were no reportable events, as that term is defined in Item 304 (a)(1)(v) of Regulation S-K.

 

A letter from Ernst & Young stating their agreement with the statements made herein is filed as Exhibit 16 to this Form 8-K.

 

During the fiscal years ended December 31, 2001 and 2000, and through March 14, 2002, the Company did not consult with PricewaterhouseCoopers regarding either:

 

(i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements; or

 

(ii) any matter that was either the subject of a disagreement, as that term is defined in Item 304 (a)(1)(iv) of Regulation S-K and the related instructions to Item 304 of Regulation S-K, or a reportable event, as that term is defined in Item 304 (a)(1)(v) of Regulation S-K.

 

Item     7.       Financial  Statements  and  Exhibits.

 

           (c)         Exhibits.

 

16            Letter  from  Ernst & Young  LLP  regarding  change  in certifying  accountant.

 

 

INDEX TO EXHIBITS

 

 

EXHIBIT

NUMBER

 

 

 

 

DESCRIPTION

 

 

 

 

 

16

 

Letter from Ernst & Young regarding its concurrence with the Registrant’s statement regarding change of accountants.

 

 



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: March 19, 2002

 

 

 

 

Tularik Inc.

 

 

 

/s/ Corinne H. Lyle

 

Corinne H. Lyle

 

Vice President, Chief Financial Officer,

 

(Principal Financial and Accounting Officer)

 

 




EX-16 3 a2073790zex-16.htm EXHIBIT 16

EXHIBIT 16

 

 

 

 

March 19, 2002

 

Securities and Exchange Commission

450 Fifth Street, NW

Washington, D.C. 20549

 

Commissioners:

 

We have read Item 4 of Form 8-K dated March 15, 2002, of Tularik Inc. and are in agreement with the statements contained in the first sentence of paragraph one, paragraph two, paragraph three and paragraph four on page two therein.  We have no basis to agree or disagree with the other statements of the registrant contained therein.

 

 

/s/ Ernst & Young LLP

 

 

 

 

 

 

 

 




-----END PRIVACY-ENHANCED MESSAGE-----